New Data Shows AbbVie's VENCLYXTO®/VENCLEXTA® Fixed Duration Combination Demonstrates Sustained Progression-Free Survival in Chronic Lymphocytic Leukemia Patients after Three Years off Treatment Biotech Investing
U.S. Food and Drug Administration Approves New Formulation of Epclusa®, Expanding Pediatric Indication to Treat Children Ages 3 and Older With Chronic Hepatitis C Biotech Investing
Wellteq to Integrate Digital Vaccination Records Through Strategic Partnership With CANImmunize Biotech Investing
BriaCell Therapeutics Announces Proceeds of US$12.88 Million from Warrant Exercises Biotech Investing
Bristol Myers Squibb Announces Positive Topline Results from Phase 3 TRANSFORM Trial Evaluating Breyanzi Versus Chemotherapy Followed by Stem Cell Transplant in Second-line Relapsed or Refractory Large B-cell Lymphoma Biotech Investing
BriaCell to Host Corporate and Clinical Update Conference Call Wednesday, June 16, 2021 at 4:30 p.m. ET Biotech Investing
Trillium Announces Voting Results From the Annual General and Special Meeting of Shareholders Biotech Investing
BioHarvest Sciences Inc. Achieves Critical Milestones in the BioFarming of Cannabis Biotech Investing
